Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axsome Thera (NQ: AXSM )

61.68 +1.13 (+1.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Axsome Thera

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Axsome Acquires Sleep Disorder Drug From Jazz Pharma, Expanding Its Neuroscience Portfolio
Axsome Therapeutics Inc (NASDAQ: AXSM) has  
Via Benzinga
Best Biotech Stocks To Buy In 2022
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and... 
Via Talk Markets
Axsome Therapeutics: Q4 Earnings Insights
Axsome Therapeutics (NASDAQ:AXSM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Agile Therapeutics (NASDAQ:AGRX) ... 
Via Benzinga
Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics
Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers ContraFect (NASDAQ:CFRX) stock mo... 
Via Benzinga
2 Top Biotech Stocks Ready for a Bull Run
Both of these companies have potential catalysts on the way. 
Via The Motley Fool
Axsome Therapeutics, inc (AXSM) Q3 2021 Earnings Call Transcript
AXSM earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Axsome Therapeutics Stock Is Rising Today
The company provided its third-quarter update. 
Via The Motley Fool
2 Biotech Stocks Poised for Jaw-Dropping Growth
These two tiny drugmakers could make early shareholders wealthy. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Why Axsome Therapeutics Stock Rocketed Higher This Week
Optimism among investors is growing for the possible approval of the biotech's MDD drug. 
Via The Motley Fool
1 Beaten-Down Stock With 10X Potential
This biotech is down, but it isn't out just yet. 
Via The Motley Fool
45 Biggest Movers From Yesterday
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on... 
Via Benzinga
Why Axsome Therapeutics Stock Caught Fire in September
This beaten-down biotech regained some lost ground last month. 
Via The Motley Fool
Why Wall Street Thinks This Biotech Stock Can Triple Your Money
The risks are huge, but so are the potential returns. 
Via The Motley Fool
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... 
Via Benzinga
Exposures COVID-19
Why Axsome Therapeutics Stock Cratered in August
An unexpected regulatory setback weighed heavily on the biotech's shares last month. 
Via The Motley Fool
3 Healthcare Stocks That Might Skyrocket When COVID Is Over
Stocks of biotech companies fighting COVID-19 have been great investments over the last two years. What stocks might zoom higher when the pandemic is over? 
Via The Motley Fool
Exposures COVID-19
Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay?
There are still plenty of unknowns related to Axsome's FDA filing. 
Via The Motley Fool
Exposures Product Safety
3 Biotech Stocks That Are Too Cheap to Ignore
You'll definitely want to check out these biotech bargains. 
Via The Motley Fool
Here's Why Axsome Therapeutics Stock Is Surging Today
The company still doesn't have much to say about the FDA and its experimental new anti-depression drug. 
Via The Motley Fool
Exposures Product Safety
10 Biggest Price Target Changes For Monday
Barclays raised Affirm Holdings, Inc. (NASDAQ:AFRM 
Via Benzinga
Which Biotech Stock Will Shock the Market in 2022?
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022? 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Regencell Bioscience (NASDAQ:RGC)... 
Via Benzinga
Why Axsome Therapeutics Stock Is Jumping Today
Investors are happy that the FDA didn't ask for more information to supplement Axsome's regulatory filing for AXS-05. 
Via The Motley Fool
Exposures Product Safety
Why Is Axsome Therapeutics (AXSM) Stock Shooting Higher On Monday?
Axsome Therapeutics Inc (NASDAQ: AXSM) stock is rising in premarket due to an update for its US marketing application seeking approval for AXS-05 for major... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 64.84% to $6.33 during Monday's pre-market session. The market value of their outstanding shares is at $144... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.